APA

Natali A., Nesti L., Venturi E., Shore A. C., Khan F., Gooding K., Gates P. E., Looker H. C., Dove F., Goncalves I., Persson M. & Nilsson J. (20190909). Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case-control study. : Diabetes, obesity & metabolism.

Chicago

Natali Andrea, Nesti Lorenzo, Venturi Elena, Shore Angela C, Khan Faisel, Gooding Kim, Gates Phillip E, Looker Helen C, Dove Fiona, Goncalves Isabel, Persson Margaretha and Nilsson Jan. 20190909. Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case-control study. : Diabetes, obesity & metabolism.

Harvard

Natali A., Nesti L., Venturi E., Shore A. C., Khan F., Gooding K., Gates P. E., Looker H. C., Dove F., Goncalves I., Persson M. and Nilsson J. (20190909). Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case-control study. : Diabetes, obesity & metabolism.

MLA

Natali Andrea, Nesti Lorenzo, Venturi Elena, Shore Angela C, Khan Faisel, Gooding Kim, Gates Phillip E, Looker Helen C, Dove Fiona, Goncalves Isabel, Persson Margaretha and Nilsson Jan. Metformin is the key factor in elevated plasma growth differentiation factor-15 levels in type 2 diabetes: A nested, case-control study. : Diabetes, obesity & metabolism. 20190909.